These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1093 related items for PubMed ID: 28260428

  • 21. Effect of renin-angiotensin system inhibitors on survival in kidney transplant recipients: A systematic review and meta-analysis.
    Jiang YM, Song TR, Qiu Y, Liu JP, Wang XD, Huang ZL, Lin T.
    Kaohsiung J Med Sci; 2018 Jan; 34(1):1-13. PubMed ID: 29310811
    [Abstract] [Full Text] [Related]

  • 22. Outcomes of de novo allograft diabetic nephropathy in renal allograft recipients.
    Prasad N, Gupta P, Jain M, Bhadauria D, Gupta A, Sharma RK, Kaul A.
    Exp Clin Transplant; 2013 Jun; 11(3):215-21. PubMed ID: 23767942
    [Abstract] [Full Text] [Related]

  • 23. Progression of graft fibrosis under mammalian target of rapamycin inhibitor-based regimen.
    Yilmaz M, Nart A, Sen S, Tasli F, Uslu A, Hur E, Ozkahya M, Hoscoskun C, Toz H.
    Nephrology (Carlton); 2010 Sep; 15(6):653-8. PubMed ID: 20883287
    [Abstract] [Full Text] [Related]

  • 24. Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Renal Transplant Recipients.
    Zakrzewska A, Tylicki L, Debska-Slizien A.
    Transplant Proc; 2018 Sep; 50(6):1834-1837. PubMed ID: 30056910
    [Abstract] [Full Text] [Related]

  • 25. Posttransplantation proteinuria: an approach to diagnosis and management.
    Shamseddin MK, Knoll GA.
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1786-93. PubMed ID: 21734095
    [Abstract] [Full Text] [Related]

  • 26. Early inhibition of the renin-angiotensin system improves the long-term graft survival of single pediatric donor kidneys transplanted in adult recipients.
    Zhang R, Laguardia H, Paramesh A, Mills K, Killackey M, McGee J, Alper B, Simon E, Lee Hamm L, Slakey D.
    Transpl Int; 2013 Jun; 26(6):601-7. PubMed ID: 23506676
    [Abstract] [Full Text] [Related]

  • 27. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B, Karakayali H, Colak T, Sevmis S, Pehlivan S, Demirhan B, Haberal M.
    Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
    [Abstract] [Full Text] [Related]

  • 28. Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers.
    Opelz G, Döhler B.
    Transplantation; 2014 Feb 15; 97(3):310-5. PubMed ID: 24492421
    [Abstract] [Full Text] [Related]

  • 29. Angiotensin blockade is associated with early graft dysfunction after live donor renal transplantation.
    Stevens KK, Patel RK, Clancy M, Jardine AG.
    Transplantation; 2010 Mar 27; 89(6):707-9. PubMed ID: 20010330
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function.
    Weir MR, Blahut S, Drachenburg C, Young C, Papademitriou J, Klassen DK, Cangro CB, Bartlett ST, Fink JC.
    Am J Nephrol; 2004 Mar 27; 24(4):379-86. PubMed ID: 15237243
    [Abstract] [Full Text] [Related]

  • 32. Determinants and patterns of renin-angiotensin system inhibitors' prescription in the first year following kidney transplantation.
    Thilly N, Bayat S, Alla F, Kessler M, Briançon S, Frimat L.
    Clin Transplant; 2008 Mar 27; 22(4):439-46. PubMed ID: 18318741
    [Abstract] [Full Text] [Related]

  • 33. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
    Yagisawa T, Omoto K, Shimizu T, Ishida H, Tanabe K.
    Nephrology (Carlton); 2015 Jul 27; 20 Suppl 2():51-7. PubMed ID: 26031587
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Outcomes of Conversion From Calcineurin Inhibitor to Belatacept-based Immunosuppression in HLA-sensitized Kidney Transplant Recipients.
    Sethi S, Najjar R, Peng A, Choi J, Lim K, Vo A, Jordan SC, Huang E.
    Transplantation; 2020 Jul 27; 104(7):1500-1507. PubMed ID: 31568398
    [Abstract] [Full Text] [Related]

  • 37. Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?
    Haas M.
    Curr Opin Nephrol Hypertens; 2014 May 27; 23(3):245-50. PubMed ID: 24626060
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.